IN8BIO, INC. Increase (Decrease) in Other Current Assets
IN8BIO, INC. (INAB) reported Increase (Decrease) in Other Current Assets of $73.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2022-11-10
- IN8BIO, INC. increase (decrease) in other current assets for the quarter ending 2022-09-30 was -$15.00K.
- IN8BIO, INC. increase (decrease) in other current assets for the quarter ending 2021-03-31 was $52.00K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month |
|---|---|---|---|
| 2022-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $73.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $88.00K 10-Q · filed 2022-08-12 | ||
| 2021-09-30 | $268.00K 10-Q · filed 2022-11-10 | ||
| 2021-03-31 | $52.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |